Get started
Author

Emily Clare Shaw

Observed names: E. Shaw, Emily C Shaw, Emily C. Shaw, Emily Shaw
Observed institutions: Royal Marsden NHS Foundation Trust, University of Liverpool, Queen Elizabeth Hospital Birmingham, Royal Brompton & Harefield NHS Foundation Trust, Cancer Research UK, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, University of Bristol, Royal Marsden Hospital, Cancer Research Horizons, NIHR CRUK Experimental Cancer Medicine Centre, University of Southampton, University College London, Saint Louis University, Salisbury NHS Foundation Trust, University of Birmingham
ORCID: 0000-0003-1424-7568
Observed ORCID: 0000-0003-1424-7568
OpenAlex ID: A5077824016
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
2017 · Nicholas McGranahan, Rachel Rosenthal, et al. · Cell · 1,294
PDF
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
2018 · Frederick Arce Vargas, Andrew J.S. Furness, et al. · Cancer Cell · 590
PDF
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
2017 · Frederick Arce Vargas, Andrew J.S. Furness, et al. · Immunity · 418
PDF
Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer
2023 · Christopher J. Hanley, Sara Waise, et al. · Nature Communications · 128
PDF
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
2022 · Yin Wu, Dhruva Biswas, et al. · Nature Cancer · 117
PDF
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
2022 · Xia Liu, Fusheng Si, et al. · Journal for ImmunoTherapy of Cancer · 99
PDF
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
2020 · Ehsan Ghorani, James L. Reading, et al. · Nature Cancer · 96
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)
2020 · Simon J. Crabb, Gareth Griffiths, et al. · Journal of Clinical Oncology · 83
PDF
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
2014 · Newton ACS Wong, David Gonzalez, et al. · Journal of Clinical Pathology · 70
PDF
Using DNA sequencing data to quantify T cell fraction and therapy response
2021 · Robert Bentham, Kevin Litchfield, et al. · Nature · 66
Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study
2014 · Anjali Char, Nick S Hopkinson, et al. · BMC Pulmonary Medicine · 38
PDF
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists
2021 · Colin R. Lindsay, Emily C. Shaw, et al. · British Journal of Cancer · 36
PDF
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study
2012 · Emily Clare Shaw, Andrew M Hanby, et al. · Journal of Clinical Pathology · 31
Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment
2021 · Carolin T. Turner, James Brown, et al. · Frontiers in Immunology · 30
PDF
Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
2019 · Kate Packwood, Guy Martland, et al. · The Journal of Pathology Clinical Research · 27
PDF
Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays
2016 · Jonathan Lawson, Rupesh J Robinson-Vyas, et al. · British Journal of Cancer · 20
PDF
An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients
2016 · Richard Baird, Ian Banks, et al. · ecancermedicalscience · 9
PDF
Ovarian Paraganglioma Arising From Mature Cystic Teratoma
2012 · Victoria J. Elliot, Emily C. Shaw, et al. · International Journal of Gynecological Pathology · 9
A collaborative approach to enabling stratified cancer medicine in the UK
2015 · Alice Tuff-Lacey, Emily Shaw, et al. · Drug Discovery Today · 8
Lessons for molecular diagnostics in oncology from the Cancer Research UK Stratified Medicine Programme
2014 · Colin R Lindsay, Emily Shaw, et al. · Expert Review of Molecular Diagnostics · 8
PDF
Hemorrhagic Bullae of the Oral Mucosa as an Early Manifestation of Vascular-Type Ehlers-Danlos Syndrome
2011 · Alexandra N. Colebatch, Emily C. Shaw, et al. · JCR Journal of Clinical Rheumatology · 8
Stratified medicine for cancer therapy
2012 · Emily C. Shaw, Peter W.M. Johnson · Drug Discovery Today · 6
Bench to bedside: research influencing clinical practice in breast cancer
2022 · Abeer M Shaaban, Emily C Shaw · Diagnostic histopathology · 4
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme
2018 · Colin R. Lindsay, Emily C. Shaw, et al. · ESMO Open · 4
PDF
Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting
2021 · Amelia Meecham, Elena Miranda, et al. · Histochemistry and Cell Biology · 3
PDF
Works count: 48
Citation count: 3,220
H-index: 16
I10-index: 16
Year
Topic
Type